Verbatim response from ChatGPT
Many U.S. telehealth providers will prescribe semaglutide (Ozempic) when a clinician determines it’s medically appropriate. Below are common telehealth options — I’ve grouped broad primary-care platforms and programs that specialize in metabolic/weight care and given a brief reason to consider each.
Primary-care and general telehealth platforms
- PlushCare — national virtual primary care; clinicians can evaluate diabetes/weight concerns, order labs, and prescribe GLP‑1s when appropriate.
- Teladoc — large, nationwide telehealth network with primary-care and specialist visits; may prescribe semaglutide after evaluation.
- Amwell — connects you with primary care and specialists (endocrinologists) who can prescribe and manage GLP‑1 therapy.
- MDLIVE — telehealth visits with primary-care clinicians who can prescribe medications subject to clinical judgment and state rules.
Weight‑loss / metabolic specialty programs (more likely to explicitly offer GLP‑1s for metabolic or weight care)
- Calibrate — a dedicated metabolic/weight-loss program that provides GLP‑1 therapy (with coaching and monitoring) as part of a structured program.
- Hims & Hers (Hers) — offers virtual weight‑loss programs that have included semaglutide/GLP‑1 options under clinician supervision.
- Lemonaid Health — telemedicine + pharmacy model that has offered semaglutide for weight-management in participating states.
- Parsley Health — membership primary-care model focused on metabolic health; clinicians may prescribe GLP‑1s as part of a treatment plan.
Other notes and cautions
- Medical eligibility: clinicians will require a medical/history review, and often labs (A1c, kidney function, etc.). Ozempic is FDA‑approved for type 2 diabetes; Wegovy (semaglutide at a different dose) is the FDA‑approved GLP‑1 for chronic weight management — some providers may prescribe Ozempic off‑label for weight loss, others won’t.
- Safety/contraindications: GLP‑1s aren’t appropriate for everyone (history of pancreatitis, certain thyroid cancers, pregnancy, etc.), so a clinician must evaluate risks.
- Access/cost: supply constraints and cost/insurance coverage vary; some telehealth programs include price transparency, medication delivery, or assistance programs.
If you tell me your state and whether you’re seeking diabetes care or a weight‑loss program, I can suggest the best options available where you live and check whether a specific service currently lists semaglutide on its menu.